Lv3
228 积分 2022-09-18 加入
[Perioperative immunotherapy for non-small cell lung cancer: consensus and controversy (2024 edition)]
1个月前
已完结
LBA58 Pathological response to neoadjuvant tislelizumab (TIS) plus platinum-doublet (PtDb) chemotherapy (CT) in resectable stage II-IIIA NSCLC patients (pts) in the phase III (Ph3) RATIONALE-315 trial
1个月前
已完结
Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World)
2个月前
已完结
Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease after Lobectomy Due to Non-Small Cell Lung Cancer—A Single-Center Retrospective Study
8个月前
已完结
皖公网安备34019202002308
